Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), sold 277,820 shares at $3.70 ($1.0M) on 2018-12-19, disclosed to the SEC on 2018-12-21.
Open-market sale of $1.0M TXMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.70 | 92,000 | $340K | 33.5% |
| 2 | $3.63 | 92,910 | $337K | 33.2% |
| 3 | $3.63 | 92,910 | $337K | 33.2% |
| Total | $3.65 avg | 277,820 | $1.0M | 100% |
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |